24 results
8-K
EX-10.1
ANEB
Anebulo Pharmaceuticals Inc
6 Oct 23
Departure of Directors or Certain Officers
4:10pm
8-K
EX-10.1
ANEB
Anebulo Pharmaceuticals Inc
28 Sep 23
Departure of Directors or Certain Officers
6:17pm
8-K
EX-10.1
ANEB
Anebulo Pharmaceuticals Inc
8 Mar 23
Entry into a Material Definitive Agreement
8:00am
8-K
EX-10.1
r5r u0d0xahur
24 May 22
Anebulo Pharmaceuticals Appoints Kenneth Cundy, Ph.D., as Chief Scientific Officer
4:05pm
8-K
EX-10.1
frrhqdceucw bmmpc
5 Jan 22
Anebulo Pharmaceuticals Names Biotechnology Industry Executive Simon Allen
10:00am
S-1
EX-10.1
l5unkmzxqq2zy dz7f
1 Apr 21
IPO registration
5:19pm
S-1
EX-10.5
ubn82o0jlleixe4
1 Apr 21
IPO registration
5:19pm
S-1
EX-10.6
lbdlff1yk
1 Apr 21
IPO registration
5:19pm
S-1
EX-10.8
5ep6g
1 Apr 21
IPO registration
5:19pm
S-1
EX-10.2
nrrw8ihrso
1 Apr 21
IPO registration
5:19pm
S-1
EX-10.7
r4hrz wsrx2
1 Apr 21
IPO registration
5:19pm
S-1
EX-10.3
lpodg
1 Apr 21
IPO registration
5:19pm
S-1
EX-10.9
w3cn8a3
1 Apr 21
IPO registration
5:19pm
S-1
EX-10.4
0z5l3875
1 Apr 21
IPO registration
5:19pm
DRS/A
EX-10.6
ozxz5wpm1
12 Mar 21
Draft registration statement (amended)
12:00am